KR20070074002A - 체온 상승성 아미노산군 의료용 제제 - Google Patents
체온 상승성 아미노산군 의료용 제제 Download PDFInfo
- Publication number
- KR20070074002A KR20070074002A KR1020077014498A KR20077014498A KR20070074002A KR 20070074002 A KR20070074002 A KR 20070074002A KR 1020077014498 A KR1020077014498 A KR 1020077014498A KR 20077014498 A KR20077014498 A KR 20077014498A KR 20070074002 A KR20070074002 A KR 20070074002A
- Authority
- KR
- South Korea
- Prior art keywords
- mol
- amino acid
- body temperature
- group
- isoleucine
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 61
- 239000003795 chemical substances by application Substances 0.000 title abstract description 5
- 229940024606 amino acid Drugs 0.000 claims abstract description 60
- 235000001014 amino acid Nutrition 0.000 claims abstract description 60
- 230000036760 body temperature Effects 0.000 claims abstract description 40
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims abstract description 19
- 239000004475 Arginine Substances 0.000 claims abstract description 19
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims abstract description 19
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims abstract description 19
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims abstract description 19
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims abstract description 19
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims abstract description 19
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 19
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 19
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims abstract description 19
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 19
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims abstract description 19
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 19
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract description 19
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims abstract description 19
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000004473 Threonine Substances 0.000 claims abstract description 19
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000004279 alanine Nutrition 0.000 claims abstract description 19
- 235000009697 arginine Nutrition 0.000 claims abstract description 19
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000013922 glutamic acid Nutrition 0.000 claims abstract description 19
- 239000004220 glutamic acid Substances 0.000 claims abstract description 19
- 235000014304 histidine Nutrition 0.000 claims abstract description 19
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000014705 isoleucine Nutrition 0.000 claims abstract description 19
- 229960000310 isoleucine Drugs 0.000 claims abstract description 19
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000005772 leucine Nutrition 0.000 claims abstract description 19
- 235000006109 methionine Nutrition 0.000 claims abstract description 19
- 229930182817 methionine Natural products 0.000 claims abstract description 19
- 235000008729 phenylalanine Nutrition 0.000 claims abstract description 19
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000004400 serine Nutrition 0.000 claims abstract description 19
- 235000002374 tyrosine Nutrition 0.000 claims abstract description 19
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000014393 valine Nutrition 0.000 claims abstract description 19
- 239000004474 valine Substances 0.000 claims abstract description 19
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 17
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims abstract description 17
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000004472 Lysine Substances 0.000 claims abstract description 17
- 235000003704 aspartic acid Nutrition 0.000 claims abstract description 17
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000018977 lysine Nutrition 0.000 claims abstract description 17
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229960004203 carnitine Drugs 0.000 claims abstract description 10
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims abstract description 9
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 claims abstract 5
- 239000000203 mixture Substances 0.000 claims description 37
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 32
- 125000000539 amino acid group Chemical group 0.000 claims description 24
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 18
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 18
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 18
- 229960003767 alanine Drugs 0.000 claims description 18
- 229960003121 arginine Drugs 0.000 claims description 18
- 229960002989 glutamic acid Drugs 0.000 claims description 18
- 229960002885 histidine Drugs 0.000 claims description 18
- 229960003136 leucine Drugs 0.000 claims description 18
- 229960004452 methionine Drugs 0.000 claims description 18
- 229960005190 phenylalanine Drugs 0.000 claims description 18
- 229960002429 proline Drugs 0.000 claims description 18
- 229960001153 serine Drugs 0.000 claims description 18
- 229960002898 threonine Drugs 0.000 claims description 18
- 229960004441 tyrosine Drugs 0.000 claims description 18
- 229960004295 valine Drugs 0.000 claims description 18
- 239000004471 Glycine Substances 0.000 claims description 16
- 229960005261 aspartic acid Drugs 0.000 claims description 16
- 229960002449 glycine Drugs 0.000 claims description 16
- 229960003646 lysine Drugs 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 15
- 239000004480 active ingredient Substances 0.000 claims description 12
- 229960004799 tryptophan Drugs 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 238000009825 accumulation Methods 0.000 abstract description 4
- 210000000577 adipose tissue Anatomy 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract 1
- 230000035622 drinking Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 241000700159 Rattus Species 0.000 description 8
- 230000037396 body weight Effects 0.000 description 8
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 229960002504 capsaicin Drugs 0.000 description 3
- 235000017663 capsaicin Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 238000009529 body temperature measurement Methods 0.000 description 2
- -1 citric acid Chemical class 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 229960005337 lysine hydrochloride Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 235000021269 warm food Nutrition 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000019654 spicy taste Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
- Seeds, Soups, And Other Foods (AREA)
Abstract
Description
아미노산 | 몰(%) |
히스티딘 | 2.6 |
아르기닌 | 3.6 |
이소류신 | 4.6 |
류신 | 6.3 |
리신염산염 | 8.8 |
페닐알라닌 | 3.9 |
티로신 | 6.1 |
발린 | 6.0 |
아스파라긴산 | 0.2 |
세린 | 2.5 |
글루타민산 | 3.3 |
프롤린 | 18.4 |
글루신 | 19.5 |
알라닌 | 6.3 |
트레오닌 | 7.4 |
메티오닌 | 0.5 |
분 | -10 | 0 | 10 | 20 | 30 | 40 | 50 |
1군 | 0.15 | 0 | 0.225 | 0.425 | 0.675 | 0.95 | 1.1 |
2군 | 0.025 | 0 | 0.35 | 0.75 | 1.275 | 1.6 | 1.9 |
3군 | -0.2 | 0 | 0.325 | 0.65 | 0.975 | 1.2 | 1.425 |
4군 | -0.2 | 0 | 0.25 | 0.5 | 0.7 | 1 | 1.275 |
분 | 60 | 70 | 80 | 90 | 100 | 110 | 120 |
1군 | 1.125 | 1.225 | 1.325 | 1.425 | 1.475 | 1.375 | 1.425 |
2군 | 2.125 | 2.425 | 2.675 | 2.8 | 2.75 | 2.775* | 2.75* |
3군 | 1.75 | 2.025 | 2.25 | 2.375 | 2.55 | 2.725* | 3.025* |
4군 | 1.5 | 1.65 | 1.75 | 2.025 | 2.125 | 2.275 | 2.375 |
분 | -10 | 0 | 10 | 20 | 30 | 40 | 50 |
1군 | 37.15 | 37 | 37.225 | 37.425 | 37.675 | 37.95 | 38.1 |
2군 | 37.125 | 37.1 | 37.45 | 37.85 | 38.375 | 38.7 | 39 |
3군 | 36.925 | 37.125 | 37.45 | 37.775 | 38.1 | 38.325 | 38.55 |
4군 | 36.65 | 36.85 | 37.1 | 37.35 | 37.55 | 37.85 | 38.125 |
분 | 60 | 70 | 80 | 90 | 100 | 110 | 120 |
1군 | 38.125 | 38.225 | 38.325 | 38.425 | 38.475 | 38.375 | 38.425 |
2군 | 39.225 | 39.525 | 39.775 | 39.9 | 39.85 | 39.875 | 39.85 |
3군 | 38.875 | 39.15 | 39.375 | 39.5 | 39.675 | 39.85 | 40.15 |
4군 | 38.35 | 38.5 | 38.6 | 38.875 | 38.975 | 39.125 | 39.225 |
아미노산 | 성분중량(%) | 몰(%) |
히스티딘 | 3.2 | 2.6 |
아르기닌 | 4.9 | 3.5 |
이소류신 | 4.7 | 4.5 |
류신 | 6.4 | 6.1 |
리신염산염 | 12.5 | 8.6 |
페닐알라닌 | 5.0 | 3.8 |
티로신 | 8.6 | 6.0 |
발린 | 5.5 | 5.9 |
아스파라긴산 | 0.2 | 0.2 |
세린 | 2.1 | 2.5 |
글루타민산 | 3.7 | 3.2 |
프롤린 | 16.5 | 18.0 |
글루신 | 11.4 | 19.1 |
알라닌 | 4.3 | 6.1 |
트레오닌 | 6.8 | 7.2 |
메티오닌 | 0.6 | 0.5 |
트립토판 | 3.6 | 2.2 |
Claims (10)
- 트레오닌, 프롤린, 글리신, 발린, 이소류신, 류신, 티로신, 페닐알라닌, 리신, 아스파라긴산, 세린, 글루타민산, 알라닌, 메티오닌, 히스티딘 및 아르기닌만으로 이루어진 군을 유효 성분으로 하는 체온 상승용 아미노산군 의료용 제제.
- 트레오닌, 프롤린, 글리신, 발린, 이소류신, 류신, 티로신, 페닐알라닌, 리신, 아스파라긴산, 세린, 글루타민산, 알라닌, 메티오닌, 히스티딘, 아르기닌 및 카르니틴만으로 이루어진 군을 유효 성분으로 하는 체온 상승용 아미노산군 의료용 제제.
- 트레오닌, 프롤린, 글리신, 발린, 이소류신, 류신, 티로신, 페닐알라닌, 리신, 아스파라긴산, 세린, 글루타민산, 알라닌, 메티오닌, 히스티딘, 아르기닌 및 트립토판만으로 이루어진 군을 유효 성분으로 하는 체온 상승용 아미노산군 의료용 제제.
- 트레오닌, 프롤린, 글리신, 발린, 이소류신, 류신, 티로신, 페닐알라닌, 리신, 아스파라긴산, 세린, 글루타민산, 알라닌, 메티오닌, 히스티딘, 아르기닌, 트립토판 및 카르니틴만으로 이루어진 군을 유효 성분으로 하는 체온 상승용 아미노산군 의료용 제제.
- 제1항 내지 제4항 중 어느 한 항에 기재된 유효 성분과 의료용으로 상용되는 첨가료만으로 이루어진 것을 특징으로 하는 체온 상승용 아미노산군 의료용 제제.
- 제1항에 있어서, 각 아미노산이 트레오닌 2∼15 몰, 프롤린 4∼30 몰, 글리신 7∼20 몰, 발린 4∼8 몰, 이소류신 3∼9 몰, 류신 2∼12 몰, 티로신 1∼9 몰, 페닐알라닌 0.5∼5 몰, 리신 5∼11 몰, 아스파라긴산 0.1∼5 몰, 세린 0.1∼5 몰, 글루타민산 0.1∼4 몰, 알라닌 0.1∼12 몰, 메티오닌 0.1∼5 몰, 히스티딘 0.1∼5 몰 및 아르기닌 0.1∼5 몰의 비율로 구성되는 것을 특징으로 하는 체온 상승용 아미노산군 의료용 제제.
- 제2항에 있어서, 각 아미노산이 트레오닌 2∼15 몰, 프롤린 4∼30 몰, 글리신 7∼20 몰, 발린 4∼8 몰, 이소류신 3∼9 몰, 류신 2∼12 몰, 티로신 1∼9 몰, 페닐알라닌 0.5∼5 몰, 리신 5∼11 몰, 아스파라긴산 0.1∼5 몰, 세린 0.1∼5 몰, 글루타민산 0.1∼4 몰, 알라닌 0.1∼12 몰, 메티오닌 0.1∼5 몰, 히스티딘 0.1∼5 몰, 아르기닌 0.1∼5 몰 및 카르니틴 0.1∼5 몰의 비율로 구성되는 것을 특징으로 하는 체온 상승용 아미노산군 의료용 제제.
- 제3항에 있어서, 각 아미노산이 트레오닌 2∼15 몰, 프롤린 4∼30 몰, 글리신 7∼20 몰, 발린 4∼8 몰, 이소류신 3∼9 몰, 류신 2∼12 몰, 티로신 1∼9 몰, 페닐알라닌 0.5∼5 몰, 리신 5∼11 몰, 아스파라긴산 0.1∼5 몰, 세린 0.1∼5 몰, 글루타민산 0.1∼4 몰, 알라닌 0.1∼12 몰, 메티오닌 0.1∼5 몰, 히스티딘 0.1∼5 몰, 아르기닌 0.1∼5 몰 및 트립토판 0.1∼5 몰의 비율로 구성되는 것을 특징으로 하는 체온 상승용 아미노산군 의료용 제제.
- 제4항에 있어서, 각 아미노산이 트레오닌 2∼15 몰, 프롤린 4∼30 몰, 글리신 7∼20 몰, 발린 4∼8 몰, 이소류신 3∼9 몰, 류신 2∼12 몰, 티로신 1∼9 몰, 페닐알라닌 0.5∼5 몰, 리신 5∼11 몰, 아스파라긴산 0.1∼5 몰, 세린 0.1∼5 몰, 글루타민산 0.1∼4 몰, 알라닌 0.1∼12 몰, 메티오닌 0.1∼5 몰, 히스티딘 0.1∼5 몰, 아르기닌 0.1∼5 몰, 트립토판 0.1∼5 몰 및 카르니틴 0.1∼5 몰의 비율로 구성되는 것을 특징으로 하는 체온 상승용 아미노산군 의료용 제제.
- 제6항 내지 제9항 중 어느 한 항에 기재한 유효 성분과 의료용으로 상용되는 첨가료만으로 이루어진 것을 특징으로 하는 체온 상승용 아미노산군 의료용 제제.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2001-00173983 | 2001-06-08 | ||
JP2001173983 | 2001-06-08 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037016015A Division KR100753879B1 (ko) | 2001-06-08 | 2002-06-06 | 체온 상승성 아미노산군 음식용 제제 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070074002A true KR20070074002A (ko) | 2007-07-10 |
KR100852930B1 KR100852930B1 (ko) | 2008-08-19 |
Family
ID=19015340
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037016015A KR100753879B1 (ko) | 2001-06-08 | 2002-06-06 | 체온 상승성 아미노산군 음식용 제제 |
KR1020077014498A KR100852930B1 (ko) | 2001-06-08 | 2002-06-06 | 체온 상승성 아미노산군 의료용 제제 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037016015A KR100753879B1 (ko) | 2001-06-08 | 2002-06-06 | 체온 상승성 아미노산군 음식용 제제 |
Country Status (13)
Country | Link |
---|---|
US (1) | US20040235923A1 (ko) |
EP (1) | EP1402788B1 (ko) |
JP (1) | JP4128524B2 (ko) |
KR (2) | KR100753879B1 (ko) |
CN (1) | CN100464647C (ko) |
AT (1) | ATE418877T1 (ko) |
AU (1) | AU2008203461B2 (ko) |
CA (1) | CA2449917C (ko) |
DE (1) | DE60230621D1 (ko) |
HK (1) | HK1064566A1 (ko) |
NZ (2) | NZ587048A (ko) |
TW (1) | TWI328450B (ko) |
WO (1) | WO2002100193A1 (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006191933A (ja) * | 2003-05-19 | 2006-07-27 | Ajinomoto Co Inc | いびき又は睡眠時の呼吸障害の予防・治療剤 |
AU2005302173B2 (en) * | 2004-11-02 | 2009-07-23 | Oragenics, Inc. | Methods for regulating weight and size of animals |
EP1818053A4 (en) * | 2004-11-02 | 2008-02-27 | Ajinomoto Kk | MEDICINE FOR THE TREATMENT / PROPHYLAXIS OF ALLERGIC DISEASES |
WO2007029730A1 (ja) * | 2005-09-06 | 2007-03-15 | Meiji Dairies Corporation | 老人性貧血を防止又は治療するためのアミノ酸組成物 |
JPWO2007060924A1 (ja) * | 2005-11-22 | 2009-05-07 | 味の素株式会社 | 膵β細胞保護剤 |
EP2492278A1 (en) * | 2006-09-18 | 2012-08-29 | Compugen Ltd. | Antibodies against an agonist of G-protein coupled receptors and its use indiagnosis and therapy |
US20080268038A1 (en) * | 2007-04-26 | 2008-10-30 | Wolfe Robert R | Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength |
JP5565016B2 (ja) * | 2009-04-08 | 2014-08-06 | ライオン株式会社 | 低体温改善用組成物及び冷え性改善用組成物 |
CN103181920A (zh) * | 2011-12-28 | 2013-07-03 | 吴顺字 | 一种防癌植物油的配方 |
WO2013168694A1 (ja) * | 2012-05-07 | 2013-11-14 | 株式会社明治 | 非糖質性エネルギー産生増強剤 |
JP2016102064A (ja) * | 2013-08-14 | 2016-06-02 | 株式会社明治 | 脂質代謝促進剤 |
US9629889B2 (en) * | 2014-10-22 | 2017-04-25 | Khanh Le | Aqueous solution formulated to raise body temperature |
CN106417597A (zh) * | 2016-08-30 | 2017-02-22 | 新疆阜丰生物科技有限公司 | 一种适用于乳酸菌饮料的复合稳定剂 |
JP2017088616A (ja) * | 2017-02-09 | 2017-05-25 | 株式会社東洋新薬 | 黒生姜含有組成物 |
PL235153B1 (pl) * | 2017-06-02 | 2020-06-01 | Gbj Pharma Spolka Z Ograniczona Odpowiedzialnoscia | Farmaceutyczna kompozycja żywieniowa dla pacjentów z odleżynami |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN85105574A (zh) * | 1985-01-17 | 1987-01-14 | 四川大学 | 从牲畜血液中提制复合氨基酸的方法 |
CN86104864A (zh) * | 1986-07-30 | 1988-02-10 | 丹东市生物化学研究所 | 复合氨基酸提取方法 |
JPH0624976A (ja) * | 1992-07-10 | 1994-02-01 | Rikagaku Kenkyusho | 輸液用組成物 |
AU679020B2 (en) * | 1992-12-23 | 1997-06-19 | Abbott Laboratories | Medical foods for the nutritional support of infant/toddler metabolic diseases |
US5728678A (en) * | 1995-06-06 | 1998-03-17 | Nestec Ltd. | Method and composition for providing nutrition to a renal failure patient |
EP0873754B1 (en) * | 1996-01-09 | 2003-07-30 | Riken | Amino acid compositions |
WO1997043912A1 (fr) * | 1996-05-23 | 1997-11-27 | Otsuka Pharmaceutical Co., Ltd. | Composition alimentaire destinee a abaisser la teneur en graisses dans le corps et a ameliorer la composition du corps et procede afferent |
US6221836B1 (en) * | 1996-07-26 | 2001-04-24 | Paxton King Beale | Composition of pyruvate and anabolic protein and method for increasing fat loss in a mammal |
ES2132021B1 (es) * | 1997-05-28 | 2000-02-16 | Riera Simon Schwartz | Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas. |
JPH10330264A (ja) * | 1997-06-02 | 1998-12-15 | Takeda Shokuhin Kogyo Kk | 脂質代謝促進組成物 |
JP3719478B2 (ja) * | 1998-03-13 | 2005-11-24 | 日本化薬株式会社 | ダイエット食品 |
JP2000228967A (ja) * | 1999-02-12 | 2000-08-22 | Bigguuesuto Sha:Kk | 脂質代謝加工食品 |
US7223417B2 (en) * | 2000-10-27 | 2007-05-29 | Calton Gary J | Nutrient formulations |
US6511696B2 (en) * | 2000-12-13 | 2003-01-28 | Novartis Nutrition Ag | Infant formula with free amino acids and nucleotides |
-
2002
- 2002-06-06 US US10/479,605 patent/US20040235923A1/en not_active Abandoned
- 2002-06-06 KR KR1020037016015A patent/KR100753879B1/ko active IP Right Grant
- 2002-06-06 CA CA002449917A patent/CA2449917C/en not_active Expired - Lifetime
- 2002-06-06 EP EP02736016A patent/EP1402788B1/en not_active Expired - Lifetime
- 2002-06-06 DE DE60230621T patent/DE60230621D1/de not_active Expired - Lifetime
- 2002-06-06 CN CNB028152662A patent/CN100464647C/zh not_active Expired - Lifetime
- 2002-06-06 NZ NZ587048A patent/NZ587048A/en not_active IP Right Cessation
- 2002-06-06 NZ NZ569905A patent/NZ569905A/en not_active IP Right Cessation
- 2002-06-06 AT AT02736016T patent/ATE418877T1/de not_active IP Right Cessation
- 2002-06-06 WO PCT/JP2002/005584 patent/WO2002100193A1/ja active Application Filing
- 2002-06-06 TW TW091112250A patent/TWI328450B/zh not_active IP Right Cessation
- 2002-06-06 JP JP2003503024A patent/JP4128524B2/ja not_active Expired - Lifetime
- 2002-06-06 KR KR1020077014498A patent/KR100852930B1/ko active IP Right Grant
-
2004
- 2004-09-27 HK HK04107453.1A patent/HK1064566A1/xx not_active IP Right Cessation
-
2008
- 2008-08-01 AU AU2008203461A patent/AU2008203461B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CA2449917A1 (en) | 2002-12-19 |
KR100753879B1 (ko) | 2007-09-03 |
AU2008203461A1 (en) | 2008-08-21 |
JPWO2002100193A1 (ja) | 2005-01-13 |
US20040235923A1 (en) | 2004-11-25 |
ATE418877T1 (de) | 2009-01-15 |
CN100464647C (zh) | 2009-03-04 |
DE60230621D1 (de) | 2009-02-12 |
CN1538812A (zh) | 2004-10-20 |
JP4128524B2 (ja) | 2008-07-30 |
EP1402788A1 (en) | 2004-03-31 |
AU2008203461B2 (en) | 2010-04-01 |
KR100852930B1 (ko) | 2008-08-19 |
NZ587048A (en) | 2012-03-30 |
EP1402788B1 (en) | 2008-12-31 |
EP1402788A4 (en) | 2006-03-22 |
KR20040016880A (ko) | 2004-02-25 |
NZ569905A (en) | 2010-09-30 |
HK1064566A1 (en) | 2005-02-04 |
TWI328450B (en) | 2010-08-11 |
CA2449917C (en) | 2009-09-22 |
WO2002100193A1 (en) | 2002-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100852930B1 (ko) | 체온 상승성 아미노산군 의료용 제제 | |
KR102093872B1 (ko) | 지방제거용 주사제 조성물 및 이의 제조방법 | |
EP1750677B1 (en) | Oral therapeutic compound delivery system | |
CN100518815C (zh) | 一种氨基酸组合物 | |
ES2965521T3 (es) | Preparación duradera de un producto inyectable de melatonina que presenta estabilidad a largo plazo | |
US10512635B2 (en) | Uses of benzimidazole derivative for nocturnal acid breakthrough | |
KR20190104921A (ko) | 사이클로 히스티딘-프롤린을 유효성분으로 포함하는 세포 보호용 조성물 | |
KR20210055052A (ko) | 아미노산 영양소, 및 아미노산 영양소를 포함하는 약제학적 조성물의 적용 | |
JP5177785B2 (ja) | 周術期患者用薬剤 | |
BR112020007447A2 (pt) | Uso da suplementação de aminoácidos na síntese da proteína muscular aprimorada | |
BRPI0720963A2 (pt) | Utilização terapêutica para o tratamento das leucemias. | |
WO2014076638A1 (es) | Composición antiparasitaria de amplio espectro de nitazoxanida, probióticos y prebióticos | |
WO2012033261A1 (ko) | 제니핀 또는 이의 유도체를 포함하는 패혈증 예방 또는 치료용 약학적 조성물 | |
JP6100510B2 (ja) | 抗感冒剤 | |
JP4829322B2 (ja) | 体温上昇飲食品用の剤 | |
JP5484704B2 (ja) | 高齢者の発熱症状抑制剤 | |
WO2004047565A1 (ja) | 体温上昇性アミノ酸含有飲食品用又は医療用の剤 | |
US20240173315A1 (en) | Trazodone oral solution | |
JP2003171266A (ja) | キシリトールを含有する解熱性調剤 | |
WO2016019313A1 (en) | Composition and method for treating restless legs syndrome and leg cramps | |
CN117462542A (zh) | Aila在治疗贫血中的应用 | |
JPH01501708A (ja) | アミノ酸の経鼻投与 | |
KR20200126354A (ko) | 진세노사이드 Rb2를 포함하는 신경세포 보호용 조성물 | |
WO2021205053A1 (es) | Composición inyectable de melatonina para el tratamiento de enfermedades virales | |
KR20060123329A (ko) | 월경 곤란증의 예방 및/또는 치료제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120724 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20130719 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140721 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20150716 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20160720 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170720 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180719 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20190722 Year of fee payment: 12 |